Lab Sciences
Top stories summarized by our editors
1/16/2019

GE Healthcare and Vanderbilt University Medical Center have entered into a five-year deal to jointly develop more precise artificial intelligence-based cancer immunotherapy diagnostics using data from thousands of VUMC patients. The partners aim to produce multiple diagnostic tools that use AI to predict potential side effects and efficacy.

Full Story:
FierceBiotech
1/16/2019

European regulators have granted Chembio Diagnostic Systems CE mark approval for a biomarker diagnostic test it developed with AstraZeneca. The quantitative test is designed to detect an undisclosed biomarker using Chembio's DPP platform, generating results within 10 minutes using a drop of blood.

Full Story:
FDAnews
1/16/2019

Guardant Health will launch its early-stage LUNAR cancer assay for research use only in the second half of 2019. The assay uses samples from a single blood draw and is capable of detecting early-stage cancer and disease recurrence based on epigenomic signatures and genomic alterations.

1/16/2019

A study of 110 people with relapsing-remitting multiple sclerosis found that nonmyeloablative hematopoietic stem cell transplantation was associated with slower disease progression than disease-modifying therapy. The findings were reported in the Journal of the American Medical Association.

1/15/2019

An implant consisting of softgel and neural stem cells was created using a 3D bioprinter and subsequently implanted in a rodent's injured spine, where new nerve cells formed and made connections with biological tissue and restored some movement in the animal's hind legs, according to findings published in Nature Medicine. Researchers used a 3D printer with an extremely high resolution to create the artificial tissue.

More Summaries:
softgel
1/15/2019

AACC is offering several recommendations to improve federal oversight of certificate of waiver testing sites, including urging lawmakers to instruct the HHS Office of Inspector General to study the quality of testing at these labs and make recommendations. It also recommends the CMS resume its CoW Laboratory Project to inspect at least 2% of waived laboratories annually.

1/15/2019

UK pharmacy chain Boots has launched an app-based urinary tract infection test that permits customers to test for infection at home using a urine kit after a consultation with a pharmacist or pharmacy adviser. The test is paired with a smartphone app that analyzes the customer's urine sample.

Full Story:
Chemist+Druggist (UK)
More Summaries:
urinary tract infection
1/15/2019

Qiagen has obtained approval from Health Canada for its in vitro tuberculosis diagnostic test, QuantiFERON-TB Gold Plus. The test, which detects latent tuberculosis infection, is the fourth generation of the technology.

Full Story:
Seeking Alpha
More Summaries:
Qiagen, Tuberculosis
1/15/2019

Health officials in the Democratic Republic of Congo said a total of 644 cases of Ebola virus infection have been reported in the current outbreak, with most of the 19 newest cases coming from a new hot spot: the community of Katwa. Meanwhile, almost 60,000 people have received the VSV-EBOV vaccine.

1/15/2019

Michigan State University researchers wanted to find out why persistent immune activation, which can lead to complications, is experienced by some HIV-positive patients, and they discovered that the immune receptor SLAMF7 remained passive in some patients with HIV who had added complications and poorer prognoses. The findings were reported in the Journal of Immunology.